Virtus Inspire Ventures logo

Virtus Inspire Ventures

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Virtus Inspire Ventures is a boutique venture capital fund that offers seed, venture, and growth stage funding.

Investor Profile

Virtus Inspire Ventures has made 8 investments, with 0 in the past 12 months and 38% as lead.

Stage Focus

  • Series C (38%)
  • Series Unknown (25%)
  • Seed (13%)
  • Series B (13%)
  • Series A (13%)

Country Focus

  • United States (63%)
  • Israel (13%)
  • France (13%)
  • China (13%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
  • Oncology
  • Diabetes
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Virtus Inspire Ventures frequently co-invest with?

AstraZeneca
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
GF Venture Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
3E Bioventures
Asia, Beijing, China, Beijing
Co-Investments: 2
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Buttonwood Group Advisors
North America, New York, United States, New York
Co-Investments: 1
InCube Ventures
North America, California, United States, San Jose
Co-Investments: 1
SV Tech Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Delian Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 2

Which angels does Virtus Inspire Ventures often collaborate with?

BS
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Virtus Inspire Ventures?

Apexigen

San Carlos, California, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

BiopharmaBiotechnologyHealth CareOncologyPharmaceutical
Series CMar 24, 2020
Amount Raised: $65,000,000
HiFiBiO

Paris, Ile-de-France, France

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series CAug 28, 2019
Amount Raised: $67,000,000
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series AJul 19, 2019
Amount Raised: $20,000,000
Apexigen

San Carlos, California, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

BiopharmaBiotechnologyHealth CareOncologyPharmaceutical
Series CAug 8, 2018
Amount Raised: $58,000,000
SmartZyme BioPharma

New York, New York, United States

SmartZyme is a medical technology company enabling a seamless leap to better performing glucose monitoring for people with diabetes.

BiotechnologyDiabetesHealth CareLife ScienceManufacturingMedical
Series BMar 14, 2018
Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 7, 2018
Amount Raised: $53,000,000
Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 27, 2016
Gordian Surgical

Misgav, HaZafon, Israel

Gordian Surgical operates within the framework of the Misgav Venture Accelerator, part of The Trendlines Group.

BiotechnologyHealth CareMedical
SeedOct 20, 2015
Amount Raised: $1,000,000